Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,057,000 | 2,595,000 | 2,094,000 | 3,411,000 | 2,561,000 |
| Marketable Securities | 10,503,000 | 15,255,000 | 12,277,000 | 17,531,000 | 16,882,000 |
| Receivables | 8,892,000 | 8,225,000 | 9,836,000 | 9,138,000 | 9,033,000 |
| Inventories | 7,415,000 | 6,783,000 | 7,507,000 | 7,614,000 | 7,578,000 |
| Income taxes - deferred | 2,791,000 | N/A | 2,825,000 | 3,127,000 | 2,888,000 |
| Other current assets | 2,220,000 | 6,091,000 | 3,962,000 | 3,024,000 | 2,356,000 |
| TOTAL | $35,878,000 | $38,949,000 | $38,501,000 | $43,845,000 | $41,298,000 |
| Non-Current Assets | |||||
| PPE Net | 13,238,000 | 13,318,000 | 13,284,000 | 13,609,000 | 13,584,000 |
| Investments And Advances | 7,346,000 | 7,116,000 | 9,507,000 | 13,124,000 | 14,146,000 |
| Intangibles | 107,083,000 | 107,097,000 | 110,519,000 | 93,656,000 | 88,160,000 |
| Other Non-Current Assets | 5,238,000 | 5,135,000 | 6,618,000 | 6,423,000 | 5,741,000 |
| TOTAL | $132,905,000 | $132,666,000 | $139,928,000 | $126,812,000 | $121,631,000 |
| Total Assets | $168,784,000 | $171,615,000 | $178,430,000 | $170,658,000 | $162,929,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,680,000 | 10,688,000 | 13,633,000 | 13,724,000 | 11,546,000 |
| Accounts payable and accrued liabilities | 3,393,000 | 4,536,000 | 3,476,000 | 3,261,000 | 3,125,000 |
| Accrued Expenses | 1,858,000 | 2,487,000 | 2,048,000 | 1,594,000 | 1,725,000 |
| Other current liabilities | 11,143,000 | 11,023,000 | 12,623,000 | 11,053,000 | 11,419,000 |
| TOTAL | $24,864,000 | $31,115,000 | $34,759,000 | $32,099,000 | $28,735,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36,330,000 | 31,398,000 | 30,437,000 | 30,457,000 | 27,824,000 |
| Other Non-Current Liabilities | 17,978,000 | 18,503,000 | 17,946,000 | 16,719,000 | 16,468,000 |
| TOTAL | $85,174,000 | $80,660,000 | $80,070,000 | $75,492,000 | $70,848,000 |
| Total Liabilities | $110,038,000 | $111,776,000 | $114,829,000 | $107,592,000 | $99,582,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,967,844 | 5,951,872 | 6,068,355 | 6,065,652 | 6,064,849 |
| Common Shares | 463,000 | 461,000 | 461,000 | 461,000 | 460,000 |
| Retained earnings | 74,847,000 | 71,774,000 | 72,846,000 | 73,350,000 | 74,971,000 |
| Other shareholders' equity | -10,261,000 | -10,716,000 | -7,894,000 | -8,570,000 | -9,214,000 |
| TOTAL | $58,746,000 | $59,840,000 | $63,601,000 | $63,066,000 | $63,347,000 |
| Total Liabilities And Equity | $168,784,000 | $171,616,000 | $178,430,000 | $170,658,000 | $162,929,000 |